Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Beamtree Holdings Ltd ( (AU:BMT) ) has shared an update.
Beamtree Holdings has reshaped its governance structure as it undertakes a strategic review aimed at unlocking shareholder value, with Chair Emma Gray stepping into a time-limited Executive Chair role to oversee the process while CEO Marek Stepniak concentrates on accelerating international sales, particularly in the U.K. and Middle East. To align leadership with shareholder returns, Gray and all non-executive directors will receive their additional remuneration and board fees entirely in equity, subject to shareholder approval, while former Calvary Health Care chief executive and ex-Health Department secretary Martin Bowles joins the board, bringing significant healthcare sector expertise to support the company’s global growth ambitions.
The most recent analyst rating on (AU:BMT) stock is a Sell with a A$0.15 price target. To see the full list of analyst forecasts on Beamtree Holdings Ltd stock, see the AU:BMT Stock Forecast page.
More about Beamtree Holdings Ltd
Beamtree Holdings Limited is an Australian healthcare technology company that provides AI-driven decision support and data insights solutions to healthcare providers globally. Its offerings span diagnostic technology, clinical decision support, coding assistance and data quality, and analytics and knowledge networks, all aimed at improving patient outcomes through data-driven automation.
Average Trading Volume: 116,326
Technical Sentiment Signal: Sell
Current Market Cap: A$46.5M
Find detailed analytics on BMT stock on TipRanks’ Stock Analysis page.